- AU$151.68m
- AU$153.95m
- AU$0.64m
Brief: Beroni Group Ltd Files For A U.S. IPO
Received Part Payment Of A $1.07 Mln Order For SARS-COV-2 Antigen Test Kit From A Japanese Pharma Co
Brief: Beroni Group Gets Approval For R&D Rebate From Australian Government
Brief: Beroni Group Says Study Of Its SARS-CoV-2 Antigen Test Kit Showed Overall Sensitivity Of 95%
Brief: Beroni Group Signs MoU With Tella, Inc To Collaborate In Immunotherapy For Cancer Treatment
Brief: Beroni Group’s Sars-Cov-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit
U.S. RESEARCH ROUNDUP-BP Midstream Partners LP, Lyft, Proofpoint
Sars-Cov-2 Antigen Test Kit Received CE Certification
Brief: Beroni Group Launches New Probiotics Health Product In China
Brief: Beroni Group Signs Agreement With Genscript Biotech To Conduct Study To Develop Nanobody-Based Medical Solution For COVID-19
Brief: Beroni Group To Supply Its SARS-COV-2 Total Antibody Detection Kit For Clinical Testing In Japan
Brief: Beroni Group Announces Submission Of Emergency Use Authorization To FDA For Covid-19 Rapid Test Detection Kit
Brief: Beroni Group Advances Research And Development Of Medical Solution For Coronavirus
Brief: Beroni Group To Launch Its Advanced U.S. FDA-Approved Virus Diagnostic Kit To Help Combat Global Outbreaks Of Zika, Dengue, Chikungunya And West Nile Viruses